Metric Snapshot
- Latest value
- 0.39
- Coverage range
- 30 Sep 2013 - 30 Jun 2023
- Fact rows
- 49
Shareable Research Card
EGRX - EAGLE PHARMACEUTICALS, INC. Earnings Per Share, Basic
This metric view shows EGRX - EAGLE PHARMACEUTICALS, INC. earnings per share, basic history from SEC company facts.
Use it to verify the latest reported value, compare nearby periods, and jump to a cross-company ranking when a curated insight exists.
- Context
- Latest reported period: Q2 2023
- Latest reported value
- 0.39
Based on company facts extracted from SEC 10-Q/10-K XBRL filings where available. Values may differ by reporting period and company taxonomy.
Financial Metric Page
EAGLE PHARMACEUTICALS, INC.: Earnings Per Share, Basic
Latest period: Q2 2023. Period end: 30 Jun 2023. Units: USD/shares. Frequency: quarterly and annual.
The amount of net income (loss) for the period per each share of common stock or unit outstanding during the reporting period.
What This Metric Tells You
- Shows the reported level of earnings per share, basic over 30 Sep 2013 - 30 Jun 2023.
- Use consecutive periods in the table to assess trend direction when YoY change is unavailable.
- Built from 49 SEC fact rows for this metric and issuer.
How To Read This Chart
- Start with the latest point, then compare it with the prior periods to see direction.
- Use quarterly sequence to compare like-for-like periods.
- Use YoY change bars to separate growth from contraction across matching periods.
- Use the TTM line to smooth quarter-to-quarter noise.
Official SEC Source
Source: SEC Company Facts
Based on company facts extracted from SEC 10-Q/10-K XBRL filings where available. Reporting periods may differ by company.
Compare This Metric Across Companies
Compare latest available Earnings Per Share, Basic levels across SEC-reporting companies, then open each company metric page for SEC-backed verification. Reporting periods may differ by company.
| Rank | Company | Latest value | Reported period | Next step |
|---|---|---|---|---|
| 1 | MachTen, Inc. (["mact"]) | 10,600,000 | Quarter - 30 Jun 2023 | Open MachTen, Inc. Earnings Per Share, Basic |
| 2 | Blue World Acquisition Corp ([]) | 5,826,667 | Quarter - 31 Mar 2022 | Open Blue World Acquisition Corp Earnings Per Share, Basic |
| 3 | CCS IX Portfolio Holdings, LLC ([]) | 724,600 | Quarter - 31 Dec 2025 | Open CCS IX Portfolio Holdings, LLC Earnings Per Share, Basic |
| 4 | Heidmar Maritime Holdings Corp. (["hmr"]) | 19,932 | Year - 31 Dec 2024 | Open Heidmar Maritime Holdings Corp. Earnings Per Share, Basic |
| 5 | BERKSHIRE HATHAWAY INC (["brkb", "brka"]) | 3,035 | Quarter - 31 Dec 2013 | Open BERKSHIRE HATHAWAY INC Earnings Per Share, Basic |
| 6 | HIGHWATER ETHANOL LLC ([]) | 1,181 | Quarter - 31 Jan 2026 | Open HIGHWATER ETHANOL LLC Earnings Per Share, Basic |
Metric Details
- Metric
- Earnings Per Share, Basic (EarningsPerShareBasic)
- Taxonomy
- us-gaap
- Units tracked
- USD/shares
- Frequency coverage
- quarterly and annual
- History range
- 30 Sep 2013 - 30 Jun 2023
- Facts on this page
- 49
- Description
- The amount of net income (loss) for the period per each share of common stock or unit outstanding during the reporting period.
- Metric-level SEC endpoint
- Open SEC company concept
Chart Context
Compare periods with the same frequency first, then use YoY and TTM series to confirm whether changes are structural or one-off.
Earnings Per Share, Basic, Trailing 12 Months (USD/shares)
Earnings Per Share, Basic, Quarterly (USD/shares)
Earnings Per Share, Basic, YoY Quarterly Change (%)
Earnings Per Share, Basic, Annual (USD/shares)
Earnings Per Share, Basic, YoY Annual Change (%)
EAGLE PHARMACEUTICALS, INC. Quarterly Earnings Per Share, Basic (USD/shares)
| Period | TTM Value | Value | YoY Chg | Change % | Start Date | End Date | Report | Filed | Fiscal Year | Fiscal Period |
|---|---|---|---|---|---|---|---|---|---|---|
| Q2 2023 | 1 | 0.39 | +1.13 | 01 Apr 2023 | 30 Jun 2023 | 10-Q/A | 09 Aug 2023 | 2023 | Q2 | |
| Q1 2023 | 0 | 0.44 | -3.03 | -87% | 01 Jan 2023 | 31 Mar 2023 | 10-Q | 09 May 2023 | 2023 | Q1 |
| Q4 2022 | 3 | 0.57 | +1.05 | 01 Oct 2022 | 31 Dec 2022 | 10-K | 23 Mar 2023 | 2022 | FY | |
| Q3 2022 | 2 | -0.54 | -0.11 | -26% | 01 Jul 2022 | 30 Sep 2022 | 10-Q | 09 Nov 2022 | 2022 | Q3 |
| Q2 2022 | 2 | -0.74 | -1.02 | -364% | 01 Apr 2022 | 30 Jun 2022 | 10-Q/A | 09 Aug 2023 | 2023 | Q2 |
| Q1 2022 | 3 | 3.47 | +3.5 | 01 Jan 2022 | 31 Mar 2022 | 10-Q | 09 May 2023 | 2023 | Q1 | |
| Q4 2021 | -1 | -0.48 | -1.08 | -180% | 01 Oct 2021 | 31 Dec 2021 | 10-K | 23 Mar 2023 | 2022 | FY |
| Q3 2021 | 0 | -0.43 | -0.95 | -183% | 01 Jul 2021 | 30 Sep 2021 | 10-Q | 09 Nov 2022 | 2022 | Q3 |
| Q2 2021 | 1 | 0.28 | +0.3 | 01 Apr 2021 | 30 Jun 2021 | 10-Q | 09 Aug 2022 | 2022 | Q2 | |
| Q1 2021 | 1 | -0.03 | +0.18 | +86% | 01 Jan 2021 | 31 Mar 2021 | 10-Q | 09 May 2022 | 2022 | Q1 |
| Q4 2020 | 1 | 0.6 | +0.52 | +650% | 01 Oct 2020 | 31 Dec 2020 | 10-K | 23 Mar 2023 | 2022 | FY |
| Q3 2020 | 0 | 0.52 | +0.69 | 01 Jul 2020 | 30 Sep 2020 | 10-Q | 09 Nov 2021 | 2021 | Q3 | |
| Q2 2020 | 0 | -0.02 | -0.51 | -104% | 01 Apr 2020 | 30 Jun 2020 | 10-Q | 09 Aug 2021 | 2021 | Q2 |
| Q1 2020 | 0 | -0.21 | -0.85 | -133% | 01 Jan 2020 | 31 Mar 2020 | 10-Q | 10 May 2021 | 2021 | Q1 |
| Q4 2019 | 1 | 0.08 | -0.78 | -91% | 01 Oct 2019 | 31 Dec 2019 | 10-K | 02 Mar 2020 | 2019 | FY |
| Q3 2019 | 2 | -0.17 | -1.11 | -118% | 01 Jul 2019 | 30 Sep 2019 | 10-Q | 02 Nov 2020 | 2020 | Q3 |
| Q2 2019 | 3 | 0.49 | +0.31 | +172% | 01 Apr 2019 | 30 Jun 2019 | 10-Q | 10 Aug 2020 | 2020 | Q2 |
| Q1 2019 | 3 | 0.64 | +0.46 | +256% | 01 Jan 2019 | 31 Mar 2019 | 10-Q | 11 May 2020 | 2020 | Q1 |
| Q4 2018 | 2 | 0.86 | +0.25 | +41% | 01 Oct 2018 | 31 Dec 2018 | 10-K | 02 Mar 2020 | 2019 | FY |
| Q3 2018 | 2 | 0.94 | -0.09 | -8.7% | 01 Jul 2018 | 30 Sep 2018 | 10-K | 02 Mar 2020 | 2019 | FY |
| Q2 2018 | 2 | 0.18 | -0.12 | -40% | 01 Apr 2018 | 30 Jun 2018 | 10-K | 02 Mar 2020 | 2019 | FY |
| Q1 2018 | 2 | 0.18 | -1.32 | -88% | 01 Jan 2018 | 31 Mar 2018 | 10-K | 02 Mar 2020 | 2019 | FY |
| Q4 2017 | 3 | 0.61 | -3.14 | -84% | 01 Oct 2017 | 31 Dec 2017 | 10-K | 28 Feb 2019 | 2018 | FY |
| Q3 2017 | 7 | 1.03 | +0.26 | +34% | 01 Jul 2017 | 30 Sep 2017 | 10-K | 28 Feb 2019 | 2018 | FY |
| Q2 2017 | 6 | 0.3 | -0.54 | -64% | 01 Apr 2017 | 30 Jun 2017 | 10-K | 28 Feb 2019 | 2018 | FY |
| Q1 2017 | 7 | 1.5 | +1.56 | 01 Jan 2017 | 31 Mar 2017 | 10-K | 28 Feb 2019 | 2018 | FY | |
| Q4 2016 | 5 | 3.75 | +3.67 | +4588% | 01 Oct 2016 | 31 Dec 2016 | 10-K | 26 Feb 2018 | 2017 | FY |
| Q3 2016 | 2 | 0.77 | +1.42 | 01 Jul 2016 | 30 Sep 2016 | 10-K | 26 Feb 2018 | 2017 | FY | |
| Q2 2016 | 0 | 0.84 | +1.37 | 01 Apr 2016 | 30 Jun 2016 | 10-K | 26 Feb 2018 | 2017 | FY | |
| Q1 2016 | -1 | -0.06 | -1.44 | -104% | 01 Jan 2016 | 31 Mar 2016 | 10-K | 26 Feb 2018 | 2017 | FY |
| Q4 2015 | 0 | 0.08 | +0.47 | 01 Oct 2015 | 31 Dec 2015 | 10-K | 15 Mar 2017 | 2016 | FY | |
| Q3 2015 | 0 | -0.65 | 0 | 0% | 01 Jul 2015 | 30 Sep 2015 | 10-K | 15 Mar 2017 | 2016 | FY |
| Q2 2015 | 0 | -0.53 | -0.32 | -152% | 01 Apr 2015 | 30 Jun 2015 | 10-K | 15 Mar 2017 | 2016 | FY |
| Q1 2015 | 0 | 1.38 | +1.74 | 01 Jan 2015 | 31 Mar 2015 | 10-K | 15 Mar 2017 | 2016 | FY | |
| Q4 2014 | -2 | -0.39 | +1.05 | +73% | 01 Oct 2014 | 31 Dec 2014 | 10-K | 15 Mar 2017 | 2016 | FY |
| Q3 2014 | -3 | -0.65 | 01 Jul 2014 | 30 Sep 2014 | 10-K | 29 Feb 2016 | 2015 | FY | ||
| Q2 2014 | -0.21 | 01 Apr 2014 | 30 Jun 2014 | 10-K | 29 Feb 2016 | 2015 | FY | |||
| Q1 2014 | -0.36 | 01 Jan 2014 | 31 Mar 2014 | 10-K | 29 Feb 2016 | 2015 | FY | |||
| Q4 2013 | -1.44 | 01 Oct 2013 | 31 Dec 2013 | 10-K | 29 Feb 2016 | 2015 | FY |
EAGLE PHARMACEUTICALS, INC. Annual Earnings Per Share, Basic (USD/shares)
| Period | Value | YoY Chg | Change % | Start Date | End Date | Report | Filed | Fiscal Year | Fiscal Period |
|---|---|---|---|---|---|---|---|---|---|
| 2022 | 2.76 | +3.42 | 01 Jan 2022 | 31 Dec 2022 | 10-K | 23 Mar 2023 | 2022 | FY | |
| 2021 | -0.66 | -1.55 | -174% | 01 Jan 2021 | 31 Dec 2021 | 10-K | 23 Mar 2023 | 2022 | FY |
| 2020 | 0.89 | -0.15 | -14% | 01 Jan 2020 | 31 Dec 2020 | 10-K | 23 Mar 2023 | 2022 | FY |
| 2019 | 1.04 | -1.12 | -52% | 01 Jan 2019 | 31 Dec 2019 | 10-K | 08 Mar 2022 | 2021 | FY |
| 2018 | 2.16 | -1.28 | -37% | 01 Jan 2018 | 31 Dec 2018 | 10-K | 05 Mar 2021 | 2020 | FY |
| 2017 | 3.44 | -1.8 | -34% | 01 Jan 2017 | 31 Dec 2017 | 10-K | 02 Mar 2020 | 2019 | FY |
| 2016 | 5.24 | +5.07 | +2982% | 01 Jan 2016 | 31 Dec 2016 | 10-K | 28 Feb 2019 | 2018 | FY |
| 2015 | 0.17 | +2.14 | 01 Jan 2015 | 31 Dec 2015 | 10-K | 26 Feb 2018 | 2017 | FY | |
| 2014 | -1.97 | +1.28 | +39% | 01 Oct 2013 | 30 Sep 2014 | 10-K | 15 Mar 2017 | 2016 | FY |
| 2013 | -3.25 | 01 Oct 2012 | 30 Sep 2013 | 10-K | 29 Feb 2016 | 2015 | FY |
* An asterisk sign (*) next to the value indicates that the value is likely invalid.